Intestinal fermentation in patients with self-reported food hypersensitivity: Painful, but protective?

Clinical and Experimental Gastroenterology

Volumn 3, Issue 1, 2010, Pages 65-70

  Valeur, Jørgen ^a,b   Morken, Mette Helvik ^a   Norin, Elisabeth ^c   Midtvedt, Tore ^c   Berstad, Arnold ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Butyrate; Dysbiosis; Gut microbiota; Irritable bowel syndrome; Short chain fatty acids

Indexed keywords

ACETIC ACID; BUTYRIC ACID; HEXANOIC ACID; PROPIONIC ACID; SHORT CHAIN FATTY ACID; VALERIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; FECES ANALYSIS; FEMALE; FOOD ALLERGY; GAS LIQUID CHROMATOGRAPHY; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MALE; SELF REPORT;

EID: 77955442043     PISSN: None     EISSN: 11787023     Source Type: Book Series    
DOI: 10.2147/ceg.s11349     Document Type: Article

References (40)

1. Berstad A, Arslan G, Lind R, Florvaag E. Food hypersensitivity-immunologic (peripheral) or cognitive (central) sensitization? Psychoneuroendocrinology. 2005;30(10):983-989.
2. Hunter JO. Food allergy - or enterometabolic disorder? Lancet. 1991; 338(8765):495-496.
3. Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr. 2002; 88 Suppl 1:S67-S72.
4. Valeur J, Morken MH, Norin E, Midtvedt T, Berstad A. Carbohydrate intolerance in patients with self-reported food hypersensitivity: comparison of lactulose and glucose. Scand J Gastroenterol. 2009;44(12): 1416-1423.
5. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136(6):2003-2014.
6. Midtvedt T, Björneklett A, Carlsten-Duke B, et al. The influence of antibiotics upon microflora associated characteristics in man and animals. In: Wostman BS, editor. Germfree Research: Microflora Control and its Application to the Biochemical Sciences. Progress in Clinical and Biological Research. New York: Alan R Liss Corporation; 1985:241-244.
7. Valeur J, Øines E, Morken MH, Holst JJ, Berstad A. Plasma glucagon-like peptide 1 and peptide YY levels are not altered in symptomatic fructose-sorbitol malabsorption. Scand J Gastroenterol. 2008;43(10): 1212-1218.
8. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395-402.
9. Zijlstra JB, Beukema J, Wolthers BG, Byrne BM, Groen A, Dankert J. Pretreatment methods prior to gaschromatographic analysis of volatile fatty acids from faecal samples. Clin Chim Acta. 1977;78(2): 243-250.
10. Hoverstad T, Fausa O, Bjorneklett A, Bohmer T. Short-chain fatty acids in the normal human feces. Scand J Gastroenterol. 1984;19(3): 375-381.
11. Cardona ME, Collinder E, Stern S, Tjellström B, Norin E, Midtvedt T. Correlation between fecal iso-butyric and iso-valeric acids in different species. Microb Ecol Health Dis. 2005;17(3):177-182.
12. Siigur U, Norin KE, Allgood G, Schlagheck T, Midtvedt T. Concentrations and correlations of faecal short-chain fatty acids and faecal water content in man. Microb Ecol Health Dis. 1994;7(6):287-294.
13. Kopecny J, Simunek J. Cellulolytic bacteria in human gut and irritable bowel syndrome. Acta Vet Brno. 2002;71:421-427.
14. Treem WR, Ahsan N, Kastoff G, Hyams JS. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr. 1996;23(3):280-286.
15. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(5):512-519, e114-e115.
16. Morken MH, Valeur J, Norin E, Midtvedt T, Nysæter G, Berstad A. Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome. Scand J Gastroenterol. 2009;44(11):1296-1303.
17. Weaver GA, Krause JA, Miller TL, Wolin MJ. Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer. Gut. 1988;29(11):1539-1543.
18. El Oufir L, Flourie B, Bruley des Varannes S, et al. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut. 1996;38(6):870-877.
19. Schwiertz A, Taras D, Schafer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18(1): 190-195.
20. Sadik R, Bjornsson E, Simren M. The relationship between symptoms, body mass index, gastrointestinal transit, and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010; 22(1):102-108.
21. Clausen MR, Bonnen H, Tvede M, Mortensen PB. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea. Gastroenterology. 1991;101(6):1497-1504.
22. Mortensen PB, Andersen JR, Arffmann S, Krag E. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol. 1987;22(2):185-192.
23. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Self-reported diarrhea: what does it mean? Am J Gastroenterol. 1994;89(8): 1160-1164.
24. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol. 2007;73(4): 1073-1078.
25. Scheppach W, Fabian C, Sachs M, Kasper H. The effect of starch malabsorption on fecal short-chain fatty acid excretion in man. Scand J Gastroenterol. 1988;23(6):755-759.
26. Perry GH, Dominy NJ, Claw KG, et al. Diet and the evolution of human amylase gene copy number variation. Nat Genet. 2007;39(10): 1256-1260.
27. Cann PA, Read NW, Cammack J, et al. Psychological stress and the passage of a standard meal through the stomach and small intestine in man. Gut. 1983;24(3):236-240.
28. Lillestøl K, Helgeland L, Arslan Lied G, et al. Indications of 'atopic bowel' in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther. 2010;31(10):1112-1122.
29. Rozovsky A, Zheng B, Metha D, Lebenthal E, Dinoso VP. Alpha glucosidase deficiencies as a possible cause of irritable bowel syndrome (IBS). Gastroenterology. 1993;104:A276.
30. Lind R, Olafsson S, Hjelland I, Berstad A, Lied GA. Lifestyle of patients with self-reported food hypersensitivity differ little from controls. Gastroenterol Nurs. 2008;31(6):401-410.
31. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133(1):24-33.
32. Balsari A, Ceccarelli A, Dubini F, Fesche E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica. 1982;5(3): 185-194.
33. Cardona ME, Midtvedt T, Norin E. Probiotics in gnotobiotic mice: Short-chain fatty acids production in vitro and in vivo. Scand J Lab Anim Sci. 2001;28(2):75-84.
34. Makras L, Falony G, Van der Meulen R, De Vuyst L. Letter to the editor. J Appl Microbiol. 2006;100:1388-1389.
35. Bourdu S, Dapoigny M, Chapuy E, et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology. 2005;128(7):1996-2008.
36. Vanhoutvin SA, Troost FJ, Kilkens TO, et al. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil. 2009;21(9):952-957, e76.
37. Born P, Bauch C, Ulm K, Kamereck K, Classen M, Scheppach W. Fecal bacterial activity in symptomatic carbohydrate malabsorption: effect on the fecal short-chain fatty acid ratio. Z Gastroenterol. 2000;38(8):623-626.
38. Dapoigny M. Effect of butyrogenic fibers in IBS patients. Sep 9, 2008. Available from: http://www.clinicaltrials.gov./ct2/show/NCT00314886?term=NCT00314886&rank=1. Accessed May 16, 2010.
39. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104-119.
40. Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 2010;105(4):859-865.